Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate for the Treatment of Gain Impairment in Parkinson's Disease: a Randomized Double-Blind, Placebo-Controlled, Cross-over Study

NCT00526630 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT00526630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00526630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate for the Treatment of Gain Impairment in Parkinson's Disease: a Randomized Double-Blind, Placebo-Controlled, Cross-over Study
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2007
Completion date
October 31, 2009
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gait impairment, parkinson's disease